SPONSOR
Maastricht University Medical Center
Total Trials
9
Recruiting
9
Phases
Phase 2, Phase 3
Conditions studied: Breast CancerBreast NeoplasmsBreast DiseasesType 2 DiabetesPreDiabetesObesityIrritable Bowel SyndromeHemorrhagic DisordersBleeding Disorder of Unknown CauseBreast Cancer Female
Maastricht University Medical Center is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Breast Cancer, Breast Neoplasms, Breast Diseases, Type 2 Diabetes.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Maastricht University Medical Center
How many clinical trials has Maastricht University Medical Center sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Maastricht University Medical Center, of which 9 are actively recruiting participants. These trials cover conditions including Breast Cancer, Breast Neoplasms, Breast Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Maastricht University Medical Center research focus on?
Maastricht University Medical Center clinical trials span Breast Cancer, Breast Neoplasms, Breast Diseases, Type 2 Diabetes, PreDiabetes, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Maastricht University Medical Center clinical trial?
To participate in a Maastricht University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Maastricht University Medical Center trials with current recruitment status updated daily.
Clinical Trials by Maastricht University Medical Center
NCT06335069 Phase 2
Recruiting
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Breast Cancer
NCT06384313
Recruiting
Butyrate-enriched Triglyceride and Diabetes Prevention
Type 2 Diabetes
NCT06090110
Recruiting
Vagal Nerve Stimulation in Irritable Bowel Syndrome
Irritable Bowel Syndrome
NCT07454161
Recruiting
Bleeding Disorder of Unknown Cause in the Netherlands
Hemorrhagic Disorders
NCT05003635
Recruiting
External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery
Breast Cancer Female
NCT04745195
Recruiting
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
Thrombotic Microangiopathies
NCT06582355
Recruiting
FMRI-neurofeedback in Parkinson's Disease
Parkinson Disease
NCT02113644
Recruiting
Prevent CardioKids
Cardiovascular Disease
NCT05367089 Phase 3
Recruiting
The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms
Candidiasis, Vulvovaginal
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology